ALZ-NET and Eisai Inc. to Collect Real-World Data to Support Postmarketing Requirements for LEQEMBI
October 04, 2024
October 04, 2024
CHICAGO, Illinois, Oct. 4 -- The Alzheimer's Association issued the following news release:
Nearly seven million Americans are living with Alzheimer's disease or a related dementia, which for decades was considered a hopeless diagnosis. However, with treatments approved by the U.S. Food and Drug Administration (FDA) that can change disease progression, coupled with more than 140 therapies aimed against Alzheimer's in clinical trials or under regulatory review, we are in a new era of . . .
Nearly seven million Americans are living with Alzheimer's disease or a related dementia, which for decades was considered a hopeless diagnosis. However, with treatments approved by the U.S. Food and Drug Administration (FDA) that can change disease progression, coupled with more than 140 therapies aimed against Alzheimer's in clinical trials or under regulatory review, we are in a new era of . . .